Barclays suggests Tesla-SpaceX merger announcement could come before December.
A call dated to December from a major bank gives traders a concrete event to price, meaning speculation about a merger is likely to directly affect Tesla and SpaceX shares. The relative reaction of the two stocks is more important than the overall movement. The share swap ratio would determine which group of shareholders benefits more, and Musk's greater voting power at SpaceX raises the question of whether Tesla investors would get equitable terms. Without confirmation from either company, the news risks a sharp reversal if no announcement materializes. Options trading in both stocks is expected to increase as traders position for a potential pre-December catalyst.
Discussion about a merger between Musk's two trillion-dollar companies has been underway for months, and Barclays has now set a tentative deadline.
Key points:
A Bloomberg report states that Barclays has pointed to a possible Tesla-SpaceX merger announcement before December. This provides a tentative timeline for a combination of Musk's two biggest firms, a topic investors have discussed for months. No further details from the Barclays note, including its rationale or any potential deal terms, were immediately accessible.
The Barclays view adds to rising speculation that began when SpaceX went public. The rocket company started trading on Nasdaq under the ticker SPCX on 12 June following a share price of $135. The IPO raised approximately $75 billion, the biggest on record, and gave SpaceX a valuation near $1.8 trillion. Earlier in February, SpaceX had taken over xAI, Musk's AI firm, in a transaction that placed the combined entity at roughly $1.25 trillion.
Musk has kept the possibility alive. During Tesla's July earnings call, he did not rule out a merger, highlighting the many areas where the companies collaborate and the increasing overlap. He stated that any transaction would need to follow the proper procedures rather than being debated on an earnings call. Tesla currently provides batteries and manufacturing tech to certain SpaceX initiatives, and the pair are co-developing Terafab, a facility aimed at producing AI chips.
Other analysts have also favored a deal. In July, JPMorgan stated that operational integration between the firms was already extensive, pointing to shared engineering staff and AI systems. Stifel noted that many investors saw a merger as a matter of timing, not if it would occur.
Major hurdles persist. JPMorgan highlighted regulatory approvals as a practical barrier, especially in China, where SpaceX's links to the US government could create national security issues for a combined company selling vehicles there. Corporate governance is another difficulty: Musk has a significantly higher voting stake in SpaceX compared to Tesla, raising questions about how Tesla's public shareholders would be treated in any merger.
Unless one of the companies confirms discussions, the Barclays assessment is just a prediction rather than an active deal, but it does give investors a timeline to monitor.
Share to
Disclaimer: this article comes from third-party media and is provided for reference only. It does not constitute investment advice. Crypto and other financial products carry significant price volatility risk, so please make your own decisions carefully.
A healthcare technology company is shifting most AI workloads to open-weight and small models, achieving major cost savings while maintaining performance.
Joe Lubin's Consensys sold all its SharpLink shares after a 94% stock collapse. The sale was at $8.39 per share, 93% below the peak.
The Nasdaq slid last week on hot inflation, growth worries, and widening credit spreads. Key focus is Friday's US Flash PMIs.
Germany and NVIDIA signed a joint declaration on industrial AI, with NVIDIA committing nearly $10 billion to European entities.